Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Incyte's enterprise value was $20.59B on Nov 11, 2026, against $18.03B a year earlier. Over the last 5 years it ranged from $8.02B to $20.78B, with a median of $12.90B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $20.59B | +21.7% |
| 2025 | Dec 31, 2025 | $16.92B | +46.5% |
| 2024 | Dec 31, 2024 | $11.54B | +9.4% |
| 2023 | Dec 29, 2023 | $10.55B | -29.1% |
| 2022 | Dec 30, 2022 | $14.89B | +6.9% |
| 2021 | Dec 31, 2021 | $13.93B | -19.5% |
| 2020 | Dec 31, 2020 | $17.30B | +2.9% |
| 2019 | Dec 31, 2019 | $16.82B | +38.4% |
| 2018 | Dec 31, 2018 | $12.15B | -35.0% |
| 2017 | Dec 29, 2017 | $18.70B | +3.0% |
| 2016 | Dec 30, 2016 | $18.16B | -7.0% |
| 2015 | Dec 31, 2015 | $19.53B | +65.4% |
| 2014 | Dec 31, 2014 | $11.81B | +50.4% |
| 2013 | Dec 31, 2013 | $7.85B | +306.1% |
| 2012 | Dec 31, 2012 | $1.93B | +22.5% |
| 2011 | Dec 30, 2011 | $1.58B | +25.8% |
| 2010 | Dec 31, 2010 | $1.25B | – |
See a number that looks wrong?